PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Staubli 11 March 2024, 13:59
Catalent: Mon 28 October 2024, 13:21
Novo Nordisk 20 March 2024, 11:21
Schott: Tue 17 September 2024, 10:51
Biosynth: Fri 4 October 2024, 10:42
HCP Engagement in a Multichannel World: Why Quality Customer Data is Critical
Clinical Research

HCP Engagement in a Multichannel World: Why Quality Customer Data is Critical

Quality customer data is foundational to commercial operations, and yet most European life sciences companies are not getting what they need from their customer d...
Continue Reading →
Technology Assisted Cohort Optimisation of Early-phase Multi-centre Patient Studies
Clinical Research

Technology Assisted Cohort Optimisation of Early-phase Multi-centre Patient Studies

The common aims of early-phase research centre around helping to define the safety, tolerability and pharmacokinetics of a drug at single or multiple doses (or ev...
Continue Reading →
Four Easy Steps to Site Optimisation
Clinical Research

Four Easy Steps to Site Optimisation

To Get the Most Out of Investigative Sites, Go After the Low-hanging Fruit In today’s clinical development arena, clinical trial sponsors are expected to achieve...
Continue Reading →
Data – The Foundation of Clinical Trials
Clinical Research

Data – The Foundation of Clinical Trials

The life sciences industry has been fundamentally altered in recent years. Diseases that were once considered life-threatening and terminal are now being manag...
Continue Reading →
Five Reasons to Rethink Paper ECGs
Clinical Research

Five Reasons to Rethink Paper ECGs

Cardiac safety issues are among the most common reasons for promising drugs being halted in development and not brought to market. The ICH E14 Guidance for Ind...
Continue Reading →
Improving Site Performance: It’s All About Relationships
Clinical Research

Improving Site Performance: It’s All About Relationships

The relationships between sponsors, CROs and study sites can present many challenges in clinical trial planning and execution. Any relationship can be complica...
Continue Reading →
Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development
Clinical Research

Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development

Central nervous system (CNS) disorders have long been the Bermuda Triangle of drug development. For example, a 2014 study of Alzheimer’s disease (AD) drugs tes...
Continue Reading →
Technology Advances in Feasibility, Recruitment and Retention
Clinical Research

Technology Advances in Feasibility, Recruitment and Retention

Biopharmaceuticals are intensely focused on efficiency and time to market; however, the nature of clinical trials continues to present obstacles to attaining the...
Continue Reading →
Rare Diseases: Ethical Considerations in the Clinical Development
Clinical Research

Rare Diseases: Ethical Considerations in the Clinical Development

The drugs used to treat rare diseases are called “orphan drugs”. There are limited numbers of patients available for enrolment in clinical trials, so it is diffi...
Continue Reading →
Proactive Pharmacovigilance- A New Model for the 21st Century
Clinical Research

Proactive Pharmacovigilance- A New Model for the 21st Century

The discipline of pharmacovigilance (PV) largely originated in reaction to public health disasters caused by medications. Sidney Kahn at Sciformix Corporation looks ...
Continue Reading →
SAE Media: Fri 25 October 2024, 10:33
PHARMAP: Mon 14 October 2024, 10.36
Automa: Mon 14 October 2024, 10:22
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Stoelzle Skyscraper: 27th November 2024
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35
Novonordisk: Wed 17 July 2024, 13:49